Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank75
3Y CAGR+178.4%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+178.4%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
21.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $10.59M | -30.0% |
| 2024 | $15.13M | +641.5% |
| 2023 | $2.04M | +315.5% |
| 2022 | $491000.00 | +12375.0% |
| 2021 | $-4000.00 | - |